Vistim Labs, founded with a mission to revolutionize the detection and treatment of neurological disorders, is a MedTech diagnostic company specializing in high-precision brain scans. Their core vision is to set a new standard in cognitive function measurement and treatment efficacy. Vistim Labs offers advanced AI software for same-day dementia evaluation, utilizing EEG visuospatial deficits to estimate clinical endpoints of dementia. Their high-resolution biomarkers correlate with traditional PET, CSF, brain atrophy, and cognitive endpoints, aiming to reduce inconclusive test results and improve diagnostic accuracy.

Notable affiliations include collaborations with academic partners who provide evidence-based support for their scientific approach. Vistim Labs has achieved significant milestones in the MedTech industry by integrating AI with traditional diagnostic methods, enhancing the precision and speed of dementia evaluations. The company's impact is evident in its contribution to more efficient and accurate neurological disorder diagnostics, potentially transforming clinical practices and patient outcomes in the field of neurology.